Mednet Logo

Do you recommend ADT for all patients who are unfavorable intermediate risk prostate cancer?

Do you only recommend ADT in patients with Gleason 4+3?
4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Rutgers Cancer Institute of New Jersey
Answered on

I recommend ADT for unfavorable intermediate risk patients who are not treated with a brachy boost. ADT is probably unnecessary for those treated with brachy boost. Of course, I also take into account the patient's concerns and preferences regarding sexuality, cardiac risk, and desire for maximal tr...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Radiation Medical Group
Answered on

When we revisit this topic, once again, we need to ask ourselves what is the goal of the added ADT?

a) Enhanced local control

b) Enhanced freedom from metastatic disease

Potent RT methods (e.g. - EBRT + brachy, high RBE SBRT) maximize local control with no ADT assist needed.

And, if we are doing ADT...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Lafayette Radiation Center
Answered on

Decipher can guide ADT use and duration in UFIR.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Radiation Therapy Consultants
Answered on

Many thanks to Dr. @Dr. First Last regarding the utility of ADT in enhancing MFS/PCSM/OS and the effect of DE RT on LC only. Does this point to the effects of inadequate staging now that we see the efficacy of PSMA PET imaging? Extreme efforts at local control of the primary are futile if occult met...

Join for free or sign in to see the full answer